Sanofi's dengue vaccine approved in Singapore and 10 other countries
Add BT as a preferred source
[PARIS] Sanofi Pasteur, Sanofi's vaccines unit, said on Tuesday that its dengue vaccine, Dengvaxia, had received market approval in eleven countries.
To date the vaccine has been approved in Mexico, the Philippines, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, Indonesia, Thailand and Singapore, the statement said.
Dengue fever is a mosquito-borne disease caused by four virus serotypes (1 to 4) as categorised by the World Health Organisation.
Overall, the disease is seen as a threat to about half of the world's population. Some 400 million people are believed to be infected annually.
REUTERS
Share with us your feedback on BT's products and services
TRENDING NOW
Singapore developer in limbo after Timor-Leste scraps major township project
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
MAS to remove mandatory financial advice for complex products for most retail investors
That ‘cheap’ Malaysia condo could cost Singapore buyers far more than they think
